| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gallagher Duncan is a Director at Health Catalyst, Inc.. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $167K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | HCAT Health Catalyst, Inc. | Director | Sell | 4,500 | $6.93 | $31,184.10 | -6.0% | -35.4% | -66.0% | |
| Dec 23, 2024 | HCAT Health Catalyst, Inc. | Director | Sell | 4,500 | $6.98 | $31,415.40 | -5.7% | -35.7% | -66.1% | |
| Aug 19, 2022 | HCAT Health Catalyst, Inc. | Director | Buy | 15,000 | $11.66 | $174,946.74 | +30.5% | -17.1% | +0.8% |